Detalhe da pesquisa
1.
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
Cell
; 184(7): 1821-1835.e16, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33667349
2.
Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo.
Immunity
; 56(8): 1927-1938.e8, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37506693
3.
Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses.
Immunity
; 55(10): 1856-1871.e6, 2022 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35987201
4.
Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies.
Cell
; 166(6): 1459-1470.e11, 2016 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27610570
5.
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody.
Cell
; 165(2): 449-63, 2016 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26949186
6.
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes.
Cell
; 163(7): 1702-15, 2015 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26687358
7.
Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability.
Immunity
; 51(5): 915-929.e7, 2019 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732167
8.
Long-primed germinal centres with enduring affinity maturation and clonal migration.
Nature
; 609(7929): 998-1004, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36131022
9.
Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop.
Immunity
; 46(5): 777-791.e10, 2017 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28514685
10.
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches.
Immunity
; 46(6): 1073-1088.e6, 2017 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28636956
11.
Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins.
Proc Natl Acad Sci U S A
; 120(24): e2216612120, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276407
12.
Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.
PLoS Pathog
; 19(10): e1011601, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903160
13.
Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor.
Immunity
; 44(4): 939-50, 2016 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27067056
14.
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies.
Immunity
; 45(3): 483-496, 2016 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27617678
15.
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody.
Proc Natl Acad Sci U S A
; 119(20): e2120976119, 2022 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549549
16.
Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer.
PLoS Pathog
; 18(11): e1010945, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36395347
17.
Author Correction: Long-primed germinal centres with enduring affinity maturation and clonal migration.
Nature
; 614(7949): E43, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36717721
18.
Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.
Retrovirology
; 20(1): 9, 2023 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37244989
19.
The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization.
J Virol
; 96(1): e0155221, 2022 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34669426
20.
Elicitation of potent serum neutralizing antibody responses in rabbits by immunization with an HIV-1 clade C trimeric Env derived from an Indian elite neutralizer.
PLoS Pathog
; 17(4): e1008977, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826683